2024-11-19 04:32:57
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
Corporate/ 2023-07-23
First HBV Patient Dosed in Phase IIa Cli...

HANGZHOU,Chinaand SHAOXING,China,Aug. 17,2020-- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Ph...

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
Corporate/ 2023-07-23
I-Mab Announces First Patient Dosed in P...

SHANGHAI and GAITHERSBERG,Md.,Aug. 17,2020-- I-Mab (the "Company") (Nasdaq: IMAB),a clinical stage biopharmaceutical company commi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release